Production (Stage)
CYduct Diagnostics, Inc.
CYDX
$0.2031
$0.0010.50%
OTC PK
| 03/31/2012 | 12/31/2011 | 09/30/2011 | 06/30/2011 | 03/31/2011 | |
|---|---|---|---|---|---|
| Revenue | 344.80K | 328.60K | 340.10K | 383.90K | 405.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 344.80K | 328.60K | 340.10K | 383.90K | 405.10K |
| Cost of Revenue | 134.70K | 134.90K | 92.60K | 114.30K | 107.90K |
| Gross Profit | 210.10K | 193.70K | 247.60K | 269.60K | 297.40K |
| SG&A Expenses | 715.50K | 1.12M | 1.56M | 1.58M | 1.64M |
| Depreciation & Amortization | 7.00K | 12.00K | 18.00K | 22.00K | 24.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 857.20K | 1.26M | 1.67M | 1.71M | 1.77M |
| Operating Income | -512.30K | -935.10K | -1.33M | -1.33M | -1.37M |
| Income Before Tax | 136.50K | -503.80K | -1.05M | -1.36M | -1.40M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.14 | -0.50 | -1.05 | -1.36 | -1.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 136.50K | -503.80K | -1.05M | -1.36M | -1.40M |
| EBIT | -512.30K | -935.10K | -1.33M | -1.33M | -1.37M |
| EBITDA | -502.30K | -923.10K | -1.31M | -1.31M | -1.34M |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |